Moderna (MRNA) EBT (2017 - 2026)
Moderna (MRNA) posted quarterly EBT of -$767.0 million for Q2 2026, up 6.23% year-over-year from -$722.0 million in Q2 2025, and up 42.5% on a QoQ basis from -$1.3 billion in Q1 2026.
Moderna (MRNA) EBT (2017 - 2026) Analysis & Trends
Moderna has reported EBT for 10 years, with the latest figure at -$767.0 million in Q2 2026.
- EBT for Q2 2026 came in at -$767.0 million, up 6.23% year-over-year; the trailing twelve-month figure through Jun 2026 was -$3.1 billion (down 4.82% YoY), and the FY2025 annual result was -$2.8 billion, up 23.26% from the prior year.
- EBT climbed to -$767.0 million in Q2 2026, from -$1.3 billion in the prior quarter.
- Over five years, EBT peaked at $4.2 billion in Q1 2022 and troughed at -$2.0 billion in Q3 2023.
- A 5-year average of -$157.9 million and a median of -$783.0 million in 2025 frame the typical range for EBT.
- The widest annual swing landed in 2022, when EBT jumped 235.63%; it then tumbled 1791.43% in 2024.
- A 5-year view of EBT shows it stood at $1.7 billion in 2022, then tumbled by 95.77% to $70.0 million in 2023, then tumbled by 1791.43% to -$1.2 billion in 2024, then jumped by 32.52% to -$799.0 million in 2025, then climbed by 4.01% to -$767.0 million in 2026.
- Per Business Quant data, the three most recent EBT figures were -$767.0 million in Q2 2026, -$1.3 billion in Q1 2026, and -$799.0 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 541.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 312.46 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,828.29 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 177.81 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -11.37 Mn |
| 10 | Moderna | 25.26 Bn | 20.13 Bn | 52.00 Mn | -767.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -767.00 Mn |
| Mar 31, 2026 | -1.33 Bn |
| Dec 31, 2025 | -799.00 Mn |
| Sep 30, 2025 | -187.00 Mn |
| Jun 30, 2025 | -818.00 Mn |
| Mar 31, 2025 | -964.00 Mn |
| Dec 31, 2024 | -1.18 Bn |
| Sep 30, 2024 | 21.00 Mn |
| Jun 30, 2024 | -1.28 Bn |
| Mar 31, 2024 | -1.17 Bn |
| Dec 31, 2023 | 70.00 Mn |
| Sep 30, 2023 | -1.96 Bn |
| Jun 30, 2023 | -1.75 Bn |
| Mar 31, 2023 | -305.00 Mn |
| Dec 31, 2022 | 1.66 Bn |
| Sep 30, 2022 | 1.22 Bn |
| Jun 30, 2022 | 2.47 Bn |
| Mar 31, 2022 | 4.23 Bn |
| Dec 31, 2021 | 5.41 Bn |
| Sep 30, 2021 | 3.55 Bn |